Literature DB >> 15700981

Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells.

Motoi Oishi1, Yukio Nagasaki, Keiji Itaka, Nobuhiro Nishiyama, Kazunori Kataoka.   

Abstract

The remarkably enhanced gene silencing in hepatoma cells was achieved by assembling lactosylated-PEG-siRNA conjugates bearing acid-labile beta-thiopropionate linkages into polyion complex (PIC) micelles through the mixing with poly(l-lysine). The PIC micelles with clustered lactose moieties on the periphery were successfully transported into hepatoma cells in a receptor-mediated manner, releasing hundreds of active siRNA molecules into the cellular interior responding to the pH decrease in the endosomal compartment. Eventually, almost 100 times enhancement in gene silencing activity compared to that of the free conjugate was achieved for the micelle system, facilitating the practical utility of siRNA therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700981     DOI: 10.1021/ja044941d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  69 in total

1.  Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.

Authors:  Jiong Zou; Fuwu Zhang; Shiyi Zhang; Stephanie F Pollack; Mahmoud Elsabahy; Jingwei Fan; Karen L Wooley
Journal:  Adv Healthc Mater       Date:  2013-08-30       Impact factor: 9.933

Review 2.  Ligand-targeted delivery of therapeutic siRNA.

Authors:  Yutaka Ikeda; Kazunari Taira
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 3.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).

Authors:  Sun Hwa Kim; Ji Hoon Jeong; Tae-il Kim; Sung Wan Kim; David A Bull
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 5.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

Review 6.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 7.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

Review 8.  Self-assembled and nanostructured siRNA delivery systems.

Authors:  Ji Hoon Jeong; Tae Gwan Park; Sun Hwa Kim
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

9.  Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding.

Authors:  Uday Ghanty; Erik Fostvedt; Rachel Valenzuela; Peter A Beal; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

Review 10.  Targeted delivery systems for oligonucleotide therapeutics.

Authors:  Bo Yu; Xiaobin Zhao; L James Lee; Robert J Lee
Journal:  AAPS J       Date:  2009-03-19       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.